These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28877727)

  • 1. Zonnic®: a new player in an old field.
    Gong M; Dunbar MS; Setodji C; Shadel WG
    Subst Abuse Treat Prev Policy; 2017 Sep; 12(1):40. PubMed ID: 28877727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products.
    Kostygina G; England L; Ling P
    Am J Public Health; 2016 Jul; 106(7):1219-22. PubMed ID: 27077338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".
    Apollonio D; Glantz SA
    Am J Public Health; 2017 Oct; 107(10):1636-1642. PubMed ID: 28817320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers.
    Caldwell B; Burgess C; Crane J
    Nicotine Tob Res; 2010 Feb; 12(2):179-83. PubMed ID: 20064899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of tobacco industry retail marketing activities of reduced harm products.
    Slater S; Giovino G; Chaloupka F
    Nicotine Tob Res; 2008 Jan; 10(1):187-93. PubMed ID: 18188759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RJ Reynolds has not published a negative randomised clinical trial of Camel Snus for smoking cessation.
    Neeley EE; Glantz SA
    Tob Control; 2017 May; 26(3):357-358. PubMed ID: 27207852
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination nicotine replacement therapy: strategies for initiation and tapering.
    Hsia SL; Myers MG; Chen TC
    Prev Med; 2017 Apr; 97():45-49. PubMed ID: 28257667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Going below the line: creating transportable brands for Australia's dark market.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii87-94. PubMed ID: 14645953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Menthol Is Key to the Tobacco Industry's Strategy of Recruiting and Retaining Young Smokers in Singapore.
    van der Eijk Y; Lee JK; M Ling P
    J Adolesc Health; 2019 Mar; 64(3):347-354. PubMed ID: 30392860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes.
    Dunsby J; Bero L
    Tob Control; 2004 Dec; 13(4):362-9. PubMed ID: 15564619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.
    Rooke C; McNeill A; Arnott D
    Nicotine Tob Res; 2013 Jun; 15(6):1052-9. PubMed ID: 23128517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications.
    Pederson LL; Nelson DE
    Nicotine Tob Res; 2007 May; 9(5):525-34. PubMed ID: 17454709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forensic analysis of online marketing for electronic nicotine delivery systems.
    Cobb NK; Brookover J; Cobb CO
    Tob Control; 2015 Mar; 24(2):128-31. PubMed ID: 24038037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Gone are the days of mass-media marketing plans and short term customer relationships": tobacco industry direct mail and database marketing strategies.
    Lewis MJ; Ling PM
    Tob Control; 2016 Jul; 25(4):430-6. PubMed ID: 26243810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does tobacco industry marketing of 'light' cigarettes give smokers a rationale for postponing quitting?
    Gilpin EA; Emery S; White MM; Pierce JP
    Nicotine Tob Res; 2002; 4 Suppl 2():S147-55. PubMed ID: 12573176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making smokers different with nicotine: NRT and quitting.
    Keane H
    Int J Drug Policy; 2013 May; 24(3):189-95. PubMed ID: 23465645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
    Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
    Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methods.
    Rees VW; Kreslake JM; Cummings KM; O'Connor RJ; Hatsukami DK; Parascandola M; Shields PG; Connolly GN
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3225-40. PubMed ID: 19959675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.